Home > PE Ratio > GENPHARMASEC

GENPHARMASEC
PE (Price/Earnings) Ratio

The Current P/E Ratio of GENPHARMASEC is 121.05.

Share Price ₹1.2Jan 23,2026
Market Cap ₹66.5 Cr
Earnings-TTM₹0.5 CrTTM-Consolidated Results
Price/Earnings121.05xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for GENPHARMASEC
Please provide your vote to see the results
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of GENPHARMASEC

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of GENPHARMASEC is calculated as :

Current Market Cap [ ₹66.5 Cr] as on Jan 23,2026

(/) Earnings [ ₹0.5 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 121.05x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for GENPHARMASEC , the investors are currently willing to pay 121.05 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of GENPHARMASEC !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of GENPHARMASEC over the last five years.

Historical PE (Price/Earnings) ratio chart of GENPHARMASEC


PE Ratio Performance Analysis for GENPHARMASEC

- GENPHARMASEC 's latest p/e ratio is 121.05x.

- GENPHARMASEC 's p/e ratio for fiscal years ending Mar2025 to Mar2023 averaged 43.09x.

- GENPHARMASEC 's operated at median p/e ratio of 46x from fiscal years ending March 2018 to 2022.

- Looking back at the last 3 fiscal years, GENPHARMASEC 's p/e ratio peaked in Mar2025 at 83.26x.

- GENPHARMASEC 's p/e ratio hit its five-year low in Mar2024 of 0x.


How does GENPHARMASEC 's P/E Ratio benchmark against top 10 peers in Dyes & Pigments Industry?

Peer Comparison (Dyes & Pigments Industry)Earnings-TTM (Cr)PE RatioMarket Cap
GENPHARMASEC 0.55121.0566.5
SUDARSHAN CHEMICAL INDUSTRIES LTD55.86124.156,935.1
KIRI INDUSTRIES LTD-208.39-13.202,751.4
VIDHI SPECIALTY FOOD INGREDIENTS LTD47.8933.081,584.0
SHREE PUSHKAR CHEMICALS & FERTILISERS LTD71.6215.351,099.6
BODAL CHEMICALS LTD35.4516.73592.8
BHAGERIA INDUSTRIES LTD48.8514.30698.5
DYNEMIC PRODUCTS LTD17.5915.13266.2
PODDAR PIGMENTS LTD17.8614.62261.1
ASAHI SONGWON COLORS LTD13.8719.68272.9
JAYSYNTH ORGOCHEM LTD15.1912.56190.8

Dyes & Pigments Industry Benchmark (Top 10) PE Analysis vs GENPHARMASEC 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE -13.20x
Max industry PE 124.15x
Median industry PE 15.35x
Average industry PE 33.95x



You may also like the below Video Courses